Varicella Vaccine Effectiveness in the US Vaccination Program: A Review
Open Access
- 1 March 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (s2) , S82-S89
- https://doi.org/10.1086/522145
Abstract
Varicella vaccine (Varivax, Merck) has been available in the United States since 1995. We reviewed published results of postlicensure studies of vaccKeywords
This publication has 38 references indexed in Scilit:
- Lack of Association between Age at Varicella Vaccination and Risk of Breakthrough Varicella, within the Northern California Kaiser Permanente Medical Care ProgramThe Journal of Infectious Diseases, 2008
- Challenges to Implementing Second‐Dose Varicella Vaccination during an Outbreak in the Absence of a Routine 2‐Dose Vaccination Requirement—Maine, 2006The Journal of Infectious Diseases, 2008
- Loss of Vaccine-Induced Immunity to Varicella over TimeNew England Journal of Medicine, 2007
- The Safety and Immunogenicity of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy ChildrenThe Pediatric Infectious Disease Journal, 2006
- Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United StatesNew England Journal of Medicine, 2005
- An Outbreak of Varicella among Children Attending Preschool and Elementary School in IllinoisClinical Infectious Diseases, 2002
- The Effectiveness of the Varicella Vaccine in Clinical PracticeNew England Journal of Medicine, 2001
- Varicella Outbreaks After Vaccine Licensure: Should They Make You Chicken?Published by American Academy of Pediatrics (AAP) ,1999
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984